150 related articles for article (PubMed ID: 28698527)
1. Engineering of a Potent Recombinant Lectin-Toxin Fusion Protein to Eliminate Human Pluripotent Stem Cells.
Tateno H; Saito S
Molecules; 2017 Jul; 22(7):. PubMed ID: 28698527
[TBL] [Abstract][Full Text] [Related]
2. Elimination of tumorigenic human pluripotent stem cells by a recombinant lectin-toxin fusion protein.
Tateno H; Onuma Y; Ito Y; Minoshima F; Saito S; Shimizu M; Aiki Y; Asashima M; Hirabayashi J
Stem Cell Reports; 2015 May; 4(5):811-20. PubMed ID: 25866158
[TBL] [Abstract][Full Text] [Related]
3. Expression and Purification of a Human Pluripotent Stem Cell-Specific Lectin Probe, rBC2LCN.
Tateno H
Methods Mol Biol; 2020; 2132():453-461. PubMed ID: 32306352
[TBL] [Abstract][Full Text] [Related]
4. Lectin drug conjugate therapy for colorectal cancer.
Kitaguchi D; Oda T; Enomoto T; Ohara Y; Owada Y; Akashi Y; Furuta T; Yu Y; Kimura S; Kuroda Y; Kurimori K; Miyazaki Y; Furuya K; Shimomura O; Tateno H
Cancer Sci; 2020 Dec; 111(12):4548-4557. PubMed ID: 33058342
[TBL] [Abstract][Full Text] [Related]
5. Oriented immobilization of rBC2LCN lectin for highly sensitive detection of human pluripotent stem cells using cell culture supernatants.
Tateno H; Hiemori K; Minoshima F; Kiyoi K; Matoba K; Katayama J; Kumada Y
J Biosci Bioeng; 2020 Feb; 129(2):215-222. PubMed ID: 31473147
[TBL] [Abstract][Full Text] [Related]
6. Systematic comparison of single-chain Fv antibody-fusion toxin constructs containing Pseudomonas Exotoxin A or saporin produced in different microbial expression systems.
Della Cristina P; Castagna M; Lombardi A; Barison E; Tagliabue G; Ceriotti A; Koutris I; Di Leandro L; Giansanti F; Vago R; Ippoliti R; Flavell SU; Flavell DJ; Colombatti M; Fabbrini MS
Microb Cell Fact; 2015 Feb; 14():19. PubMed ID: 25889802
[TBL] [Abstract][Full Text] [Related]
7. A technique for removing tumourigenic pluripotent stem cells using rBC2LCN lectin.
Haramoto Y; Onuma Y; Mawaribuchi S; Nakajima Y; Aiki Y; Higuchi K; Shimizu M; Tateno H; Hirabayashi J; Ito Y
Regen Ther; 2020 Jun; 14():306-314. PubMed ID: 32462059
[TBL] [Abstract][Full Text] [Related]
8. [Construction, expression and functional characterization of disulfide-stabilized anti-hepatocarcinoma single chain Fv fused with truncated Pseudomonas exotoxin].
Zhao J; Sun ZW; Liu YF; Yu WY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Nov; 19(6):585-7. PubMed ID: 15182657
[TBL] [Abstract][Full Text] [Related]
9. Molecular construction and characterization of a novel exotoxin fusion protein that selectively blocks the B7:CD28 costimulatory signal system.
Xi Y; Yuan Z; Zhang H; Guan H; Kong F; Liu N; Liang F; Cui J; Guo S; Sun Y; Xi C
J Immunother; 2006; 29(6):586-95. PubMed ID: 17063121
[TBL] [Abstract][Full Text] [Related]
10. Podocalyxin is a glycoprotein ligand of the human pluripotent stem cell-specific probe rBC2LCN.
Tateno H; Matsushima A; Hiemori K; Onuma Y; Ito Y; Hasehira K; Nishimura K; Ohtaka M; Takayasu S; Nakanishi M; Ikehara Y; Nakanishi M; Ohnuma K; Chan T; Toyoda M; Akutsu H; Umezawa A; Asashima M; Hirabayashi J
Stem Cells Transl Med; 2013 Apr; 2(4):265-73. PubMed ID: 23526252
[TBL] [Abstract][Full Text] [Related]
11. Live-cell imaging of human pluripotent stem cells by a novel lectin probe rBC2LCN.
Tateno H; Onuma Y; Ito Y
Methods Mol Biol; 2014; 1200():313-8. PubMed ID: 25117245
[TBL] [Abstract][Full Text] [Related]
12. Target-specific cytotoxic effects on HER2-expressing cells by the tripartite fusion toxin ZHER2:2891-ABD-PE38X8, including a targeting affibody molecule and a half-life extension domain.
Liu H; Seijsing J; Frejd FY; Tolmachev V; Gräslund T
Int J Oncol; 2015 Aug; 47(2):601-9. PubMed ID: 26046132
[TBL] [Abstract][Full Text] [Related]
13. [Soluble expression of recombinant immunotoxin against human bladder carcinoma and its anti-tumor activity].
Chao K; He D; Yang H; Zhang Z; Lin Q; Guo AG; Huang HL
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Sep; 20(5):568-71. PubMed ID: 15367349
[TBL] [Abstract][Full Text] [Related]
14. Optimization of expression and purification of two biologically active chimeric fusion proteins that consist of human interleukin-13 and Pseudomonas exotoxin in Escherichia coli.
Joshi BH; Puri RK
Protein Expr Purif; 2005 Feb; 39(2):189-98. PubMed ID: 15642470
[TBL] [Abstract][Full Text] [Related]
15. [Studies of the expression, purification, renaturation and biologic activity of an anti-CEA immunotoxin].
Yang H; He D; Chao K; Lin Q; You S; Huang HL
Sheng Wu Gong Cheng Xue Bao; 2004 May; 20(3):348-51. PubMed ID: 15971603
[TBL] [Abstract][Full Text] [Related]
16. Photoactivable Elimination of Tumorigenic Human Induced Pluripotent Stem Cells by Using a Lectin-Doxorubicin Prodrug Conjugate.
Dion J; Minoshima F; Saito S; Kiyoi K; Hasehira K; Tateno H
Chembiochem; 2019 Jun; 20(12):1606-1611. PubMed ID: 30737871
[TBL] [Abstract][Full Text] [Related]
17. Fusions of anthrax toxin lethal factor to the ADP-ribosylation domain of Pseudomonas exotoxin A are potent cytotoxins which are translocated to the cytosol of mammalian cells.
Arora N; Klimpel KR; Singh Y; Leppla SH
J Biol Chem; 1992 Aug; 267(22):15542-8. PubMed ID: 1639793
[TBL] [Abstract][Full Text] [Related]
18. [Construction of interleukin-18-PE38 fusion gene eukaryotic expression vector and its expression in the. chondrocyte].
Wu X; Zhang L; Qu Y; Li MY; Jiang ZH; Li H
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jul; 36(4):456-9. PubMed ID: 16078559
[TBL] [Abstract][Full Text] [Related]
19. Generation of Potent Anti-HER1/2 Immunotoxins by Protein Ligation Using Split Inteins.
Pirzer T; Becher KS; Rieker M; Meckel T; Mootz HD; Kolmar H
ACS Chem Biol; 2018 Aug; 13(8):2058-2066. PubMed ID: 29920062
[TBL] [Abstract][Full Text] [Related]
20. Higher cytotoxicity of divalent antibody-toxins than monovalent antibody-toxins.
Won J; Nam P; Lee Y; Choe M
Biochem Biophys Res Commun; 2009 Apr; 382(1):15-20. PubMed ID: 19245794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
